Results 41 to 50 of about 413,699 (314)
Wolfberry polysaccharide protects primary cortical neurons from homocysteine-induced neurotoxicity [PDF]
The 9th International Conference of the Alzheimer's and Parkinson's Diseases: Advances, concepts and new Challenges, Prague, Czech Republic, 11-15 March 2009. In Neurodegenerative Diseases, 2009, v. 6 suppl.
Yu, MS +5 more
core +2 more sources
Background With the availability of first disease-modifying treatments, evidence on costs across the entire Alzheimer's Continuum, especially for early disease stages, becomes increasingly important to inform healthcare planning, resource allocation, and
Eva Gläser +25 more
doaj +1 more source
Mitochondrial remodeling shapes neural and glial lineage progression by matching metabolic supply with demand. Elevated OXPHOS supports differentiation and myelin formation, while myelin compaction lowers mitochondrial dependence, revealing mitochondria as key drivers of developmental energy adaptation.
Sahitya Ranjan Biswas +3 more
wiley +1 more source
Pharmacotherapy of Neurodegenerative Diseases
Amyotrophic Lateral Sclerosis (ALS) is a fatal idiopathic neurodegenerative disease that is characterized by degeneration of both upper and lower motor neurons. ALS currently only has 2 drugs approved as disease modyfying, whereas the rest of the therapy
Adem, Muna Abdu
core
Peroxiredoxins in Neurodegenerative Diseases [PDF]
Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance was long overshadowed by the other well-studied ROS ...
openaire +3 more sources
The ubiquitin ligase RNF115 is required for the clearance of damaged lysosomes
Upon lysosomal rupture, an E3 ubiquitin ligase RNF115 translocates from the cytosol to the damaged lysosomal membrane. Moreover, RNF115 depletion impairs the clearance of damaged lysosomes, identifying it as a key regulator of lysosomal quality control.
Sae Nakanaga +3 more
wiley +1 more source
Dysfunction of the episodic memory network in the Alzheimer’s disease cascade
Alzheimer’s disease (AD) is a major cause of dementia and cognitive decline. Here, we assessed how episodic memory (EM) network dysfunction, a hallmark of AD, is related to the longitudinal progression of AD biomarkers, neurodegeneration and cognition ...
René Lattmann +43 more
doaj +1 more source
pH‐mediated activation of the lysosomal arginine sensor SLC38A9
Cells monitor nutrient levels via the lysosomal transporter SLC38A9 to activate the mechanistic target of rapamycin complex 1 (mTORC1). This study reveals that SLC38A9 function is regulated by pH. We identified histidine 544 as a critical pH sensor that undergoes conformational changes to control amino acid efflux from lysosomes; therefore, it ...
Xuelang Mu, Ampon Sae Her, Tamir Gonen
wiley +1 more source
Memory in Neurodegenerative Disease [PDF]
Memory in Neurodegenerative Disease . Edited by alexander i troster. (Pp 413, £60.00 (US $95.00). Published by Cambridge University Press, Cambridge 1998. ISBN 0-521-57192-8. No one can doubt the increasing importance, to affected families and the healthcare system, of Alzheimer’s disease, Parkinson’s disease, and the other degenerative conditions of ...
openaire +2 more sources
Study on Genotypes and Phenotypes of Neurodegenerative Diseases
Neurodegenerative diseases are a heterogeneous group of age-related disorders characterised by the progressive degeneration or death of neurons in the central or peripheral nervous system. The prevalence of these diseases is increasing, in part due to an
Claudia Ricci
core +2 more sources

